Biofourmis Raises $100M in Series C

Biofourmis has successfully raised $100M in a Series C at a $500M valuation led by SoftBank Vision Fund 2, Openspace Ventures.

Company Overview

Biofourmis is a HealthTech company headquartered in Boston, MA, founded in 2015 with 300+ employees.

AI-powered patient analytics platform

Fundraising Details

Amount Raised: $100M
Round Type: Series C
Valuation: $500M
Date: 2021-05-25
Investors: SoftBank Vision Fund 2, Openspace Ventures

About Biofourmis

AI-powered patient analytics platform The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.

Key Information

Headquarters: Boston, MA
Founded: 2015
Team Size: 300+
Industry: HealthTech

What This Means

This funding round demonstrates strong investor confidence in Biofourmis's vision and execution. The capital will likely be used to:

Scale Operations: Expand the team and operational capacity
Product Development: Enhance existing products and develop new features
Market Expansion: Enter new markets and strengthen presence in existing ones
Technology Investment: Invest in infrastructure and technology capabilities

Industry Context

The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Biofourmis's successful fundraising reflects the strong fundamentals and growth potential in this space.

Valuation Milestone

Reaching a $500M valuation marks an important milestone for Biofourmis, positioning the company among notable players in the HealthTech industry.

Looking Ahead

With this new capital, Biofourmis is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.

This fundraising news was reported on 2021-05-25. For more information about Biofourmis, visit their headquarters at Boston, MA.